Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 4, 1997, Pages 691-702

  Phillips, Tamara J ^a,b   Wenger, Charlotte D ^a   Dorow, Janet D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Acquisition; Alcohol Intake; C57BL 6J Mice; Chronic; Naltrexone

Indexed keywords

ALCOHOL; NALTREXONE; OPIATE RECEPTOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030911094     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb03824.x     Document Type: Article

References (101)

1. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881-887, 1992
2. O'Malley SS: Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence. J Clin Psychiatry 56(Suppl. 7):30-38, 1995
3. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
4. Volpicelli JR, Clay KL, Watson NT, Volpicelli LA: Naltrexone and the treatment of alcohol dependence. Alcohol Health Res World 18:272-278, 1994
5. Volpicelli JR, Clay KL, Watson NT, O'Brien CP: Naltrexone in the treatment of alcoholism: Predicting response to naltrexone. J Clin Psychiatry 56(Suppl. 7):39-44, 1995
6. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H: Naltexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467, 1994
7. Swift RM: Effect of naltrexone on human alcohol consumption. J Clin Psychiatry 56(Suppl. 7):24-29, 1995
8. Make E, Malec T, Gangé MA, Dongier M: Buspirone in the treatment of alcohol dependence: A placebo-controlled trial Alcohol Clin Exp Res 20:307-312, 1996
9. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neiderhiser D, Nocks JJ, Shaw S: Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA 256:1449-1455, 1986
10. Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkerneker U, Willenbring M, Fiscella R, Sather MR: Lithium treatment of depressed and nondepressed alcoholics. JAMA 262:1646-1652, 1989
11. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995
12. Brewer C: Naltrexone in alcohol dependence. Lancet 346:1374, 1995
13. Azrin NH, Sisson RW, Meyers R, Godley M: Alcoholism treatment by disulfiram and community reinforcement therapy. J Behav Ther Exp Psychiatry 13:105-112, 1982
14. Mansour A, Fox CA, Akil H, Watson SJ: Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29, 1995
15. Koob GF: Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Sci 13:177-184, 1992
16. Self DW, Nestler EJ: Molecular mechanisms of drug reinforcement and addiction, Annu Rev Neurosci 18:463-495, 1995
17. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP: Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry 152:613-615, 1995
18. O'Malley SS, Jaffe AJ, Rode S, Rounsaville BJ: Experience of a "slip" among alcoholics treated with naltrexone or placebo. Am J Psychiatry 153:281-283, 1996
19. Iso H, Brush FR: Opposite effects of naltarexone on ETOH intake by Syracuse high and low avoidance rats. Alcohol 8:443-448, 1991
20. De Witte P: Naloxone reduces alcohol in a free-choice procedure even when both drinking bottles contain saccharin sodium or quinine substances. Neuropsychobiology 12:73-77, 1984
21. Beaman CM, Hunter GA, Dunn LL, Reid LD: Opioids, benzodiazepines and intake of ethanol. Alcohol 1:39-42, 1984
22. Reid LD, Hunter GA: Morphine and naloxone modulate intake of ethanol. Alcohol 1:33-37, 1984
23. Samson HH, Doyle TF: Oral ethanol self-administration in the rat: Effect of naloxone. Pharmacol Biochem 22:91-99, 1985
24. Pulvirenti L, Kastin AJ: Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: Correlation with degree of spontaneous preference. Pharmacol Biochem Behav 31:129-134, 1988
25. Hubbell CL. Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD: Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39-54, 1986
26. Hubbell CL, Marglin SH, Spitalnic SJ, Abelson ML, Wild KD, Reid LD: Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 8:355-367, 1991
27. Weiss F, Mitchiner M, Bloom FE, Koob GF: Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology 101:178-186, 1990
28. Hyytiä P, Sinclair JD: Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin Exp Res 17:631-636, 1993
29. Lê AD, Poulos CX, Quan B, Chow S: The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted paradigm. Brain Res 630:330-332, 1993
30. Ulm RR, Volpicelli JR, Volpicelli LA: Opiates and alcohol self-administration in animals. J Clin Psychiatry 56(Suppl. 7):5-14, 1995
31. Altshuler HL, Phillips PE, Feinhandler DA: Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688, 1980
32. Myers RD, Borg S, Mossberg R: Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 3:383-388, 1986
33. Kornet M, Goosen C, Van Ree JM: Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 104:367-376, 1991
34. Koob GF, Pettit HO, Ettenberg A, Bloom FE: Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J Pharmacol Exp Ther 229:481-486, 1984
35. Vaccarino FJ, Bloom FE, Koob GF: Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86:37-42, 1985
36. Corrigall WA, Vaccarino FJ: Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol Biochem Behav 30:443-450, 1988
37. Corrigall WA, Coen KM: Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170, 1991
38. Hereby SE, Smith JE, Dworkin SI: The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J Pharmacol Exp Ther 277:1247-1258, 1996
39. Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ: Opioids and consummatory behavior. Brain Res Bull 14:663-672, 1985
40. Lynch WC: Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol Biochem Behav 24:833-836, 1986
41. Schwarz-Stevens KS, Files FJ, Samson HH: Effects of morphine and naloxone on ethanol- and sucrose-reinforced responding in nondeprived rats. Alcohol Clin Exp Res 16:822-832, 1992
42. Beczkowska IW, Koch JE, Bostock ME, Leibowitz SF, Bodnar RJ: Central opioid receptor subtype antagonists differentially reduce intake of and maltose dextrin solutions in rats. Res 618:261-270, 1993
43. Krishnan-Sarin S, ling S-L, Kurtz DL, Zweifel M, Portoghese PS, Li T-K, Froehlich JC: The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology 120:177-185, 1995
44. Ransey NF, Van Ree JM: Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 40:807-810, 1991
45. McClearn GE, Rodgers DA: Differences in alcohol preference among inbred strains of mice. Q J Stud Alcohol 20:691-695, 1959
46. Elmer GI, Meisch RA, Goldberg SR, George FR: Fixed-ratio schedules of oral ethanol self-administration in inbred mouse strains. Psychopharmacology 96:431-436, 1988
47. George SR, Roldan L, Lui A, Naranjo CA: Endogenous opioids are involved in the genetically determined high preference for ethanol consumption. Alcohol Clin Exp Res 15:668-672, 1991
48. Lê AD, Ko J, Chow S, Quan B: Alcohol consumption by C57BL/6, BALB/c, and DBA/2 in a limited paradigm. Pharmacol Biochem Behav 47:375-378, 1994
49. Rodriguez LA, Plomin R, Blizard DA, Jones BC, McClearn GE: Alcohol acceptance, preference, and sensitivity in mice. I. Quantitative genetic analysis using BXD recombinant inbred strains. Alcohol Clin Exp Res 18:1416-1422, 1994
50. Phillips TJ, Crabbe JC Metten P, Belknap J: Localization of genes affecting alcohol drinking in mice. Alcohol Clin Exp Res 18:931-941, 1994
51. Crabbe JC, Kosobud A, Tam BR, Young ER, Deutsch CM: Genetic selection of mouse lines sensitive (COLD) and resistant (HOT) to ethanol hypothermia. Alcohol Drug Res 7:163-174, 1987
52. Belknap JK, Haltli NR, Goebel DM, Lamé M: Selective breeding for high and low levels of opiate-induced analgesia in mice. Behav Genet 13:383-396, 1983
53. Samson HH: Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res 10:436-442, 1986
54. Grisel JE, Fleshner M, Watkins LR, Maier SF: Opioid and non-opioid interactions in two of stress-induced analgesia. Pharmacol Biochem Behav 45:161-172, 1993
55. Volpicelli JR, Ulm RR, Hopson N: The bidirectional effects of shock on alcohol preference in rats. Alcohol Clin Exp Res 14:913-916, 1990
56. Fidler TL, LoLordo VM: Failure to find postshock increases in ethanol preference. Alcohol Clin Exp Res 20:110-121, 1996
57. Yoburn BC, Cohen AH, Inturrisi CE: Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. J Pharmacol Exp Ther 237:126-130, 1986
58. Sinclair JD: Drugs to decrease alcohol drinking. Ann Med 22:357-362, 1990
59. Sinden JD, Marfaing-Jallat P, Le Magnen J: The effect of naloxone on intragastric ethanol self-administration. Pharmacol Biochem Behav 19:1045-1048, 1983
60. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li T-K: Importance of delta opioid receptors in maintaining high alcohol drinking, Psychopharmacology 103:467-472, 1991
61. Froehlich JC, Harts J, Lumeng L, Li T-K: Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385-390, 1990
62. Brush FR, Froehlich JC, Sakellaris PC: Genetic selection for avoidance behavior in the rat. Behav Genet 9:309-316, 1979
63. Tempel A, Gardner EL, Zukin RS: Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther 232:439-444, 1985
64. Chang S-CJL, Lutfy K, Sierra V, Yoburn BC: Dissociation of opioid receptor upregulation and functional supersensitivity. Pharmacol Biochem 38:853-859, 1991
65. Côté TE, Izenwasser S, Weems HB: Naltrexone-induced upregulation of Mu opioid receptors on 7315e cell and brain membranes: Enhancement of opioid efficacy in inhibiting adenylyl cyclase. J Pharmacol Exp Ther 267:238-244, 1993
66. Yoburn BC, Shah S, Chan K, Duttaroy A, Davis T: Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity. Pharmacol Biochem Behav 51:535-539, 1995
67. Ayesta FJ, Ableitner A, Emmett-Oglesby MW, Herz A, Shippenberg TS: Paradoxical effects of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation. J Pharmacol Exp Ther 260:168-174, 1992
68. Duttaroy A, Billings B, Candido J, Yoburn BC: Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity. Eur J Pharmacol 221:211-215, 1992
69. Bardo MT, Neisewander JL: Chronic naltrexone supersenitzes the reinforcing and locomotor-activating effects of morphine. Pharmacol Biochem Behav 28:267-273, 1987
70. Bardo MT, Neisewander JL, Ennis RB: Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: Neurochemical and behavioral evidence. Neuropharmacology 27:1103-1109, 1988
71. Weiss F, Lorang MT, Bloom FE, Kooh GF: Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: Genetic and motivational determinants. J Pharmacol Exp Ther 267:250-258, 1993
72. Lanca AJ: Reduction of voluntary alcohol intake in the rat by modulation of the dopaminergic mesolimbic system: Transplantation of ventral mesencephalic cell suspensions. Neuroscience 58:359-369, 1994
73. Spanagel R, Herz A, Shippenberg TS: The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J Neurochem 55:1734-1740, 1990
74. Spanagel R, Herz A, Shippenberg TS: Opposing tonicatly active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050, 1992
75. Benjamin D, Grant ER, Pohorecky LA: Naltrexone reverses ethanol-induced dopamine release in the nucleus aceumbens in awake, freely moving rats. Brain Res 621:137-140, 1993
76. Gonzalez JP, Brogden RN: Naltrexone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 35:192-213, 1988
77. Lee MC, Wagner HN, Tanada S, Frost JJ, Bice AN, Dannals RF: Duration of occupancy of opiate receptors by naltrexone. J Nucl Med 29:1207-1211, 1988
78. Belknap JK, Crabbe JC, Young ER: Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112:503-510, 1993
79. Phillips TJ, Crabbe JC Jr: Behavioral studies of genetic differences in alcohol action, in Crabbe JC Jr, Harris RA (eds): The Genetic Basis of Alcohol and Drug Actions. New York, Plenum Press, 1991, pp 25-104
80. Schuckit MA: Biological vulnerability to alcoholism. J Consult Clin Psychol 55:301-309, 1987
81. Goldman D: Genetic transmission, in Gonzalez JP, Brogden RN (eds): Recent Developments in Alcoholism, vol 11: Ten Years of Progress. New York, Plenum Press, 1993, pp 231-248
82. Rodriguez LA, Plomin R, Blizard DA, Jones BC, McClearn GE: Alcohol acceptance, preference, and sensitivity in mice. II. Quantitative trait loci mapping analysis using BXD recombinant inbred strains. Alcohol Clin Exp Res 19:367-373, 1995
83. Melo JA, Shendure J, Pociask K, Silver LM: Identification of sex-specific quantitative trait loci controlling alcohol preference in C57BL/6 mice. Nature Genet 13:147-153, 1996
84. Rezvani AH, Overstreet DH, Janowsky DS: Genetic serotonin deficiency and alcohol preference in the Fawn Hooded rats. Alcohol Alcohol 25:573-575, 1990
85. Overstreet DH, Kampov-Polevoy AB, Rezvani AH, Murrelle L, Halikas JA, Janowsky DS: Saccharin intake predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcohol Clin Exp Res 17:366-369, 1993
86. 3H-serotonin uptake. I. A study in Fawn-Hooded rats. Life Sci 48:1969-1976, 1991
87. Rezvani AH, Garges PL, Miller DB, Gordon CJ: Attenuation of alcohol consumption by MDMA (Ecstasy) in two strains of alcohol-preferring rats. Pharmacol Biochem Behav 43:103-100, 1992
88. Rezvani AH, Grady DR: Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacol Biochem Behav 48:105-110, 1994
89. McMillen BA, Williams HL: Volitional consumption of ethanol by Fawn-Hooded rats: Effects of alternative solutions and drug treatments. Alcohol 12:345-350, 1995
90. Ng GYk, George SR: Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse. Eur J Pharmacol 269:365-374, 1994
91. George SR, Fan T, Ng GYk, Jung SY, O'Dowd BF, Naranjo CA: Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: Reversal by increasing synaptic dopamine. J Exp Ther 273:373-379, 1995
92. Lhuintre JP, Moore N, Tran G, Steru L, Langrenon S, Daoust M, Parot PH, Ladure Ph, Libert C, Boismare F, Hillemand B: Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 25:613-622, 1990
93. Petry NM: Ro 15-4513 selectively attenuates ethanol, but not sucrose, reinforced responding in a concurrent access procedure: Comparison to other drugs. Psychopharmacology 121:192-203, 1995
94. Rassnick S, D'Amico E, Riley E, Pulvirenti L, Zieglgansberger W, Koob GF: GABA and nucleus accumbens glutamate neurotransmission modulate ethanol self-administration in rats. NY Acad Sci 654:502-505, 1992
95. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: Clinical evidence. Biol Psychiatry 36:326-337, 1994
96. LeMarqauand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, dependence: Findings of animal studies. Biol Psychiatry 36:395-421, 1994
97. Belknap IK, Coleman RR, Foster K: Alcohol consumption and sensory threshold differences between C57BL/6J DBA/2J mice. Psychol 6:71-74, 1978
98. Forgie ML, Beyerstein BL, Alexander BK: Contributions of taste factors and gender to opioid preference in C57BL and DBA mice. Psychopharmacology 95:237-244, 1988
99. Lancaster FE, Spiegel KS: Sex differences in pattern of drinking. Alcohol 9:415-420, 1992
100. Stewart RB, Russell RN, Lumeng L, Li T-K, Murphy JM: Consumption of sweet, salty, sour, and bitter solutions by selectively bred alcohol-preferring and alcohol-nonpreferring lines of rats. Alcohol Clin Exp Res 18:375-381, 1994
101. Bachmanov AA, Tordoff MG, Beauchamp GK: Ethanol consumption and taste preferences in C57BL/6ByJ and 129/J mice. Alcohol Clin Exp Res 20:201-212, 1996